Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer

Tadahiro Nozoe, Emiko Nozoe, Tomohiro Iguchi, Shuhei Ito, Takefumi Ohga, Tetsuya Koga, Takahiro Ezaki

Research output: Contribution to journalArticle

Abstract

A 67-year-old woman after mastectomy was afflicted with local recurrence of left breast cancer during adjuvant trastuzumab therapy. Oral administration of lapatinib and capecitabine served to distinguish the recurrent tumor and also reduce the patient's distressing symptoms. This combined anti-cancer therapy may be available for patients with breast cancer for whom trastuzumab therapy was not adequately effective.

Original languageEnglish
Pages (from-to)907-908
Number of pages2
JournalJapanese Journal of Cancer and Chemotherapy
Volume40
Issue number7
Publication statusPublished - Jul 2013

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Nozoe, T., Nozoe, E., Iguchi, T., Ito, S., Ohga, T., Koga, T., & Ezaki, T. (2013). Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer. Japanese Journal of Cancer and Chemotherapy, 40(7), 907-908.